[1] |
SHI Dawei, ZHENG Xiaoyong, JIN Xiaodan, ZHAO Xiaoman, CHEN Jie, DU Xingjun.
Implication of XPC rs2228001 polymorphism on the prognosis of patients with colorectal cancer who were treated with capecitabine-based adjuvant chemotherapy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 391-399.
|
[2] |
WU Zhiyong, LIU Bingrong, LI Bin, TANG Rui.
Value of red blood cell distribution width in predicting early poor neurologic improvement after intravenous thrombolysis in patients with ischemic stroke
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 307-314.
|
[3] |
HUANG Kaige, XU Qinhua, WANG Wei.
Interaction effect and predictive efficacy of blood glucose and blood calcium on the prognosis of patients with acute severe pancreatitis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1227-1234.
|
[4] |
ZHENG Hongbo , YAO Wenlong , LUO Ailin, ZHOU Biyun.
Application of remimazolam combined with propofol in painless endoscopic retrograde cholangiopancreatography
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1154-1160.
|
[5] |
HUANG Xiaoming, DU Ye, LIN Shaoming, SHEN Guanle.
Exploratory study of the influence of respiratory microbiology on the efficacy of PD-1 inhibitors monotherapy for patients with advanced non-small cell lung cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 66-74.
|
[6] |
ZENG Xiaofan, XU Yiqi, LIU Shu, WU Qian, LI Zibao, HE Junjun, JIN Yuelong, ZHAO Yongli, HE Chunling, GAO Jialin.
Retrospectively analysis of the effect of low-dose aspirin on primary prevention of non-fatal myocardial infarction and cerebral infarction in patients with type 2 diabetes mellitus
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 665-671.
|
[7] |
ZHU Xinru, HUANG Xin.
Roles of indoxyl sulfate in complications of chronic kidney disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 672-679.
|
[8] |
LIU Le, QI Wenbo, BAI Yuping, LIU Qian, YIN Zhenyu, LI Xiaomei, YU Yang, CHEN Hao.
Influencing factors of PD-1/PD-L1 immune checkpoint inhibitor immunotherapy for gastric cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(1): 95-101.
|
[9] |
TIAN Yali, FENG Lin, ZHAO Wan, GU Min, SHEN Hanjing, CHAI Xiaoyan.
Correlation of BRCA1 gene polymorphism with chemosensitivity and prognosis of metastatic esophageal squamous cell carcinoma treated with cisplatin combined with capecitabine
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(10): 1118-1126.
|
[10] |
JIANG Weijie, HE Haibo, TANG Hongbo, HE Junyu.
Research progress on the relationship between nuclear factor-κB in placenta and pregnancy complications
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(1): 82-87.
|
[11] |
XU Honglei, XU Bingxin, ZU Qing, ZHAO Yan, GAO Pengfei, YU Yang.
Effects of CYP2C19 gene polymorphism on the clinical prognosis of clopidogrel in elderly patients with acute cerebral infarction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(9): 1014-1020.
|
[12] |
WANG Xianghai, XING Min, LYU Tangfeng, LIU Hongbing, SONG Yong.
Effects of knocking down long intergenic non-coding RNA 00467 on the prognosis of patients with lung adenocarcinoma and its mechanism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(8): 841-849.
|
[13] |
ZHANG Dezhi, LIU Meng, ZHU Shaogong, LIU Guiju, JI Jie.
Efficacy and safety of XELOX therapy in comparison with capecitabine monotherapy in adjuvant chemotherapy for elderly patients with colorectal cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(8): 926-936.
|
[14] |
LI Rongzhen, MEI Jiazhuan, XIA Yunzhan, JI Jie.
Prognostic factors and safety study of R0 resection colorectal cancer patients received capecitabine based adjuvant chemotherapy in real world
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(6): 704-711.
|
[15] |
FANG Chuanchuan, NI Guantai, JIN Lan, LIU Ji, LIU Xiaoqing, QIAO Chun, LUO Yonghong.
Correlation between phosphorylation of PEA-15-Ser104 site and prognosis of epithelial ovarian cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(5): 523-528.
|